Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of medical decision support systems (DDX generators) using real medical cases of varying complexity and origin.

BMC medical informatics and decision making·2022

Same author

[Erratum to: Metabolic acidosis : Diagnosis and treatment].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020

Same author

Interdisciplinary consensus on indications for transfemoral transcatheter aortic valve implantation (TF-TAVI) : Joint Consensus Document of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte e.V. (ALKK) and cooperating Cardiac Surgery Departments.

Clinical research in cardiology : official journal of the German Cardiac Society·2019

Same author

[Metabolic acidosis : Diagnosis and treatment].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2019

Same author

Renal complications of cancer therapies.

Drugs of today (Barcelona, Spain : 1998)·2018

Same author

Risk prediction of acute kidney injury by [TIMP-2]•[IGFBP7].

Drugs of today (Barcelona, Spain : 1998)·2017

Search research articles

Related Experiment Video

Updated: May 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

[Cardiorenal syndrome].

M D Alscher¹, U Sechtem

¹Abteilung für Allgemeine Innere Medizin und Nephrologie, Robert-Bosch-Krankenhaus Stuttgart, Auerbachstraße 110, Stuttgart, Germany. dominik.alscher@rbk.de

|January 26, 2012

Summary

Cardiorenal syndrome, where heart failure worsens kidney function, requires careful diuretic therapy or ultrafiltration. Close collaboration between cardiologists and nephrologists is crucial for managing this condition.

Area of Science:

Cardiology
Nephrology
Internal Medicine

Context:

Cardiorenal syndrome (CRS) presents a common clinical challenge where managing acute cardiac decompensation is complicated by deteriorating renal function.
This condition often coexists with pre-existing chronic kidney disease, increasing patient risk.
CRS necessitates careful management to avoid complications such as inadequate volume depletion.

Purpose:

To highlight the complexities of managing cardiorenal syndrome.
To discuss therapeutic strategies including diuretic therapy and ultrafiltration.
To emphasize the importance of interdisciplinary collaboration in treating CRS.

Summary:

Therapy for acute cardiac decompensation can be limited by declining renal function, a hallmark of cardiorenal syndrome (CRS).

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Experiment Videos

Last Updated: May 25, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Cautious diuretic administration is vital to prevent volume depletion, potentially requiring intensive care unit monitoring.

Ultrafiltration offers an alternative or adjunct to diuretics, allowing for controlled fluid removal and improved volume management as heart failure symptoms resolve.

Impact:

Improved understanding of cardiorenal syndrome management strategies.
Enhanced patient outcomes through optimized fluid management and interdisciplinary care.
Reduced morbidity and mortality associated with cardiorenal syndrome.